Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Stephen A. Brunton"'
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-20 (2023)
Abstract Background Heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus (T2DM) are common and interrelated conditions, each with a significant burden of disease. HF and kidney disease progress through pathophysiologic pathw
Externí odkaz:
https://doaj.org/article/90e60517bb2c4456b6c5af8495b9ce78
Autor:
Stephen A. Brunton
Publikováno v:
Clinical diabetes : a publication of the American Diabetes Association. 40(4)
Publikováno v:
Diabetes Spectr
Autor:
Rong Zhou, Andres DiGenio, Mehul Dalal, Keith L. Davis, Juliana Meyers, Stephen A. Brunton, Pavan Chava, Lawrence Blonde
Publikováno v:
Diabetes Spectrum : A Publication of the American Diabetes Association
Objective. Many patients with type 2 diabetes do not reach glycemic goals despite basal insulin treatment. This study assessed the achievement of a target A1C Methods. This was a retrospective analysis of pooled randomized controlled trial (RCT) data
Publikováno v:
Postgraduate medicine. 132(sup2)
Oral semaglutide is the first US Food and Drug Administration-approved oral glucagon-like peptide-1 receptor agonist (GLP-1RA) for the treatment of type 2 diabetes (T2D). Prior articles within this supplement reviewed the PIONEER trial program, which
Autor:
Stephen A Brunton, Carol Wysham
Publikováno v:
Postgraduate medicine. 132(sup2)
Glucagon-like peptide-1 (GLP-1) is a hormone of the incretin system responsible for a variety of glucoregulatory effects, including glucose-dependent secretion of insulin and inhibition of glucagon release, the effects of which are impaired in people
Autor:
Neil S, Skolnik, Trang Susan, Nguyen, Aarisha, Shrestha, Riju, Ray, Thomas C, Corbridge, Stephen A, Brunton
Publikováno v:
Postgraduate medicine. 132(2)
Long-acting inhaled bronchodilator medications are recommended as initial maintenance therapy for many patients with COPD. These medications include long-acting muscarinic antagonists (LAMA) and long-acting β
Autor:
Stephen A, Brunton
Publikováno v:
The Journal of family practice. 67
Type 2 diabetes (T2D) is a debilitating condition and more people are being diagnosed each year. T2D increases patients' risk of developing disabling micro- and macrovascular complications, significantly reduces patients' quality of life, and is a su
Publikováno v:
The Journal of family practice. 66
The importance of treatment adherence is well established, as poor adherence contributes to disease progression and increased morbidity and mortality. Analysis of 11,272 veterans with T2DM with a mean follow-up of 5 years showed that for each 10% inc